Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Alamar Biosciences, Inc. before investing.

In this article, we go over a few key elements for understanding Alamar Biosciences, Inc.’s stock price such as:

• Alamar Biosciences, Inc.’s current stock price and volume
• Why Alamar Biosciences, Inc.’s stock price changed recently
• Upgrades and downgrades for ALMR from analysts
• ALMR’s stock price momentum as measured by its relative strength

About Alamar Biosciences, Inc. (ALMR)

Before we jump into Alamar Biosciences, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company’s offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. The company was incorporated in 2018 and is based in Fremont, California.

Want to learn more about Alamar Biosciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Alamar Biosciences, Inc..

Alamar Biosciences, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Alamar Biosciences, Inc.’s stock price was $25.360.

Alamar Biosciences, Inc. is up 1.16% from its previous closing price of $25.070.

During the last market session, Alamar Biosciences, Inc.’s stock traded between $24.700 and $26.360. Currently, there are approximately 12.26 million shares outstanding for Alamar Biosciences, Inc..

Alamar Biosciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Alamar Biosciences, Inc. Stock Price History

Alamar Biosciences, Inc.’s (ALMR) price is currently down 6.39% so far this month.

During the month of July, Alamar Biosciences, Inc.’s stock price has reached a high of $29.430 and a low of $23.320.

Over the last year, Alamar Biosciences, Inc. has hit prices as high as $29.430 and as low as $18.845.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Alamar Biosciences, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded Alamar Biosciences, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Alamar Biosciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Alamar Biosciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Alamar Biosciences, Inc. (ALMR) by visiting AAII Stock Evaluator.

Relative Price Strength of Alamar Biosciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Alamar Biosciences, Inc. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Alamar Biosciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Alamar Biosciences, Inc. Stock Price: Bottom Line

As of July 31, 2026, Alamar Biosciences, Inc.’s stock price is $25.360, which is up 1.16% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Alamar Biosciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.